* NOVOTEC *
1997 - Rhône-Alpes
Lyon
www.novotec-labs.com Contract, Manufacturing
Key words: Antibodies, Extra cellular matrix (ECM), Tissue-samples, Immunochemistry, Histology
Mission: to develop, produce and distribute species specific antibodies directed against macro-molecules of the Extracellular Matrix (ECM), to prepare tissue analysis
Clients: Pharmaceutical industry, Cosmetic industry, Biotechs, Academic and Industry Research labs
novotec@novotec-labs.com
Age: 14 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Spin-off |
Managing Dir.-CEO: Guerret (Sylviane) [born 1950] et Hartmann (Danielle) [born 1953]
Sc.Dir.-CSO: Hartmann (Daniel)
Fin.Dir.-CFO:
BusDev: Prulière (Franck)
Financers (Hist.): privately owned (registered capital 2006 = 0.065 M€)
Note: no communication policy on web site | Turnover (M€) : 0.45 (2010), 0.43 (2009), 0.37 (2008), 0.3 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Subcontractor
Company confirm : 2-May-2011 |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 1997 .11 | Company founded by Sylviane Guerret, as a spin-off from Institut Pasteur, Lyon | ORGF | [0 year] | Actualisation / Updating: 2-May-2011 |
|
